Akebia Therapeutics | AKBA - أصول متداولة





أصول متداولة تغيير تاريخ
Acadia Pharmaceuticals USD 1.27B 43.88M 2026-09
Agios Pharmaceuticals USD 752.1M 34.43M 2026-09
Akebia Therapeutics USD 220.78M 8.77M 2026-09
Alnylam Pharmaceuticals USD 5.11B 492.49M 2026-09
Amgen USD 34.36B 598M 2026-09
Ardelyx USD 441.39M 538K 2026-09
Astellas Pharma JPY 1.44T 41.22B 2026-09
AstraZeneca USD 31.45B 3.48B 2026-09
Bayer EUR 39.6B 5.96B 2026-09
BioMarin Pharmaceutical USD 3.92B 50.99M 2026-09
Celltrion KRW 493.66B 12.09B 2026-06
Cspc Pharmaceutical CNY 22.25B 359.48M 2025-12
Deva Holding AS TRY 9.13B 1.61B 2023-09
Dianthus Therapeutics USD 856.04M 41.5M 2026-09
Exelixis USD 1.32B 70.8M 2026-09
Fresenius Medical Care EUR 7.84B 150.6M 2026-09
GlaxoSmithKline GBP 17.9B 336M 2026-09
Ionis Pharmaceuticals USD 2.36B 129.77M 2026-09
Ironwood Pharmaceuticals USD 225.99M 26.79M 2026-09
J&J USD 56.35B 3.42B 2026-09
Kangmei Pharma CNY 6.66B 143.43M 2026-06
Karyopharm Therapeutics USD 126.33M 23.19M 2026-03
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Laboratorios Farma EUR 509.33M 128.63M 2023-12
Lexicon Pharmaceuticals USD 186.03M 84.14M 2026-03
Malin Corporation EUR 62.6M 26.7M 2024-12
Medical Developments International AUD 33.75M 1.79M 2025-12
Moderna USD 7.34B 1.53B 2026-09
Nektar Therapeutics USD 589.04M 322.77M 2026-03
Neuren Pharmaceuticals AUD 332.23M 11.98M 2025-12
Organigram Holdings CAD 280.09M 30M 2026-06
Ovoca Bio EUR 2.07M 510K 2025-12
Pharma Mar EUR 295.56M 14.62M 2026-09
Prothena USD 273.86M 18.15M 2026-09
PTC Therapeutics USD 2.54B 79.58M 2026-09
Qiagen NV USD 1.66B 116.37M 2026-06
Regeneron Pharmaceuticals USD 20.8B 2.35B 2026-09
Roche Holding CHF 35.44B 3.29B 2026-06
Sanofi EUR 33.21B 1.68B 2026-09
Sarepta Therapeutics USD 2.27B 49.06M 2026-09
Sartorius EUR 1.65B 8.4M 2026-09
Sino Biopharmaceutical CNY 33.82B 9.13B 2025-06
Tectonic Therapeutic USD 231.1M 8.79M 2026-06
Tilray USD 729.32M 28.18M 2025-09
Vanda Pharmaceuticals USD 347.26M 20.23M 2025-12
Zealand Pharma A/S 15.02B 652.12M 2026-03
Zz Pientze Pharmaceu CNY 13.48B 2.32B 2026-09